Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.
May 17, 2023
Data from Benchmark Registry Demonstrate Improved TAVR Efficiency with Preserved Patient Safety
May 17, 2023 — Edwards Lifesciences announced that new data from the Benchmark Registry in Europe demonstrated the…
Read More
Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).
May 17, 2023
EuroPCR Late-Breaking Clinical Trial Data Finds Effectiveness of Elixir Medical’s DynamX Bioadaptor for PCI Treatment
May 17, 2023 — Elixir Medical has reported that important data were presented at a late-breaking clinical session…
Read More
Heart Rhythm 2023, the society's 44th annual meeting, taking place May 19-21, in New Orleans
By Melinda Taschetta-Millane
May 17, 2023
HRS23 Announces Late-breaking Clinical Trials and Science Sessions
The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical…
Read More
Photo courtesy of James McCabe
May 16, 2023
Prowess, Persistence Yield First-anywhere Heart Procedure
March 16, 2023 — Cardiologists at the UW Medicine Heart Institute recently performed a first-in-the-world procedure,…
Read More
Fred Casciano, with wife Annette, is first patient to receive a new cath lab coronary artery bypass procedure at Henry Ford Health in Detroit.
May 16, 2023
Henry Ford Health Cardiologists look to the Past to Create New Heart Bypass Procedure
May 16, 2023 — Henry Ford Health Interventional cardiologists William O’Neill, M.D., and Khaldoon Alaswad, M.D., took a…
Read More
Philips Dynamic Coronary Roadmap
May 16, 2023
Philips’ Image-guided Navigation Increases Safety During Coronary Interventions
May 16, 2023 —  Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast…
Read More
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 billion by 2026. With a CAGR of 14.4% over the forecast period
By Kelly Patrick
May 15, 2023
Ambulatory Diagnostic Cardiology Market to Hit $3.3 Billion by 2026
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3…
Read More
CRF Meeting on Structural Heart Disease Innovations will take place June 7-10
May 15, 2023
TVT 2023 Late-breaking Science Announced
May 15, 2023 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will…
Read More
Presentations include data on pulsed field ablation (PFA), disparities in atrial fibrillation (AFib) management, role of mapping and digital technologies in advancing cardiac arrhythmia treatment and real-world evidence informing treatment pathways
May 15, 2023
Biosense Webster Highlights New Research and Technology to Advance AFib Treatment at Heart Rhythm 2023
May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases
May 15, 2023
Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360 BioPharma Research System
May 15, 2023 — Cardio Diagnostics Holdings, Inc, a precision cardiovascular medicine company, today announced the…
Read More
The Amvia family enables physiological pacing and workflow optimization to help physicians deliver exceptional patient-centric care with less effort.
May 12, 2023
Biotronic Receives CE Approval for the World’s First Pacemaker and CRT-P Family Approved for Left Bundle Branch Pacing
May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted…
Read More
Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA)
May 12, 2023
Concept Medical's Receives FDA Approval for the MagicTouch-Sirolimus Coated Balloon
May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s…
Read More
A heart muscle cell with mutations in the gene that makes the Rotatin protein (bottom) has disorganized muscle fibers (red) compared to healthy heart muscle cell (top).
May 11, 2023
Research Identifies New Cause of Heart Failure Condition in Children
May 11, 2023 — In an effort to determine the cause behind a rare condition that causes heart failure in children,…
Read More
On this occasion, it unveiled MyLab Omega eXP, a new portable ultrasound system featuring advanced cardio tools and AI-powered automation and showcased Suitestensa CVIS, an all-in-one cardiovascular management solution for enterprises, and Caas Qardia, a cutting-edge echocardiography software platform
May 11, 2023
The Esaote Group Unveiled MyLab Omega eXP at EACVI2023
May 11, 2023 — Esaote, a leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI…
Read More
May 11, 2023
Under 40s with Mental Health Problems Have Elevated Risks of Heart Attack and Stroke
May 11, 2023 — Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a…
Read More
The randomized controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients
May 10, 2023
Oxygen Therapy Improves Heart Function in Patients with Long COVID
May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy…
Read More
This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases
May 10, 2023
Women are Underrepresented in Cardiovascular Clinical Trials
May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials (…
Read More
The AIMed Global Summit will be held June 4-7, 2023, at the San Diego Convention Center, featuring a comprehensive agenda of key leaders and wide-ranging sessions on artificial intelligence (AI), its application, opportunities and implications on healthcare.
By Christine Book
May 10, 2023
AiMed Global Summit 2023 to Focus on “Changing Healthcare One Connection at a Time” in San Diego
May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered…
Read More
INSPIRIS RESILIA aortic valve
May 09, 2023
Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year Data
May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of…
Read More
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early detection of heart disease, announces completion of patient enrollment for its MyoVista wavECG pivotal study for FDA De Novo submission.
May 09, 2023
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG
May 9, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now